Peking University Cancer Hospital & Institute

This study tests a combination of chemotherapy drugs and an immunotherapy drug (sintilimab) given before and after surgery for a rare type of stomach cancer called HER2-negative hepatoid adenocarcinoma. The goal is to see if this approach can shrink tumors and improve outcomes. A…

This early-phase study tests a new combination treatment for people with extensive-stage small cell lung cancer (ES-SCLC) whose tumors have a specific marker (SSTR). After completing standard first-line therapy, participants will receive a targeted radioactive drug ([225Ac]Ac-DOT…

This study looks at how well a drug called Trop-2 ADC (sacituzumab govitecan) works for breast cancer patients whose cancer has spread to the brain. Researchers will track 100 patients from multiple hospitals to see if the drug shrinks brain tumors and how safe it is. The goal is…

This study is testing a drug called adebrelimab (SHR-1316) combined with chemotherapy for people with a type of esophageal cancer that can be surgically removed. The treatment is given before and after surgery to see if it helps shrink tumors and prevent cancer from coming back. …

This study tests whether a combination of the immunotherapy drug camrelizumab and chemotherapy can shrink esophageal tumors enough to avoid surgery and keep the esophagus intact. About 283 adults with resectable esophageal squamous cell cancer will receive the treatment before an…

This study tests a combination of three drugs (RC48, chemotherapy, and an immunotherapy) given before and after surgery for a rare stomach cancer called hepatoid adenocarcinoma. The goal is to see if this approach can completely eliminate the tumor before surgery and prevent it f…

This early-phase study tests a new PET imaging probe designed to detect clear cell renal cell carcinoma, a common type of kidney cancer. The probe targets a protein called CAIX, which is found in high levels on these cancer cells but not on most normal tissues. The goal is to see…

This study tests a new imaging probe called 89Zr-s-C1 that attaches to a protein (MUC18) found on many solid tumors. The goal is to see if this PET/CT scan can find tumors that standard scans miss. About 20 adults with newly diagnosed or recurrent solid tumors will receive the pr…

This study tests a new radioactive tracer called [68Ga]N188 to see if it can better detect bladder cancer on PET scans. About 20 adults with urothelial carcinoma, including those with advanced or recurrent disease, will receive the tracer and undergo imaging. The goal is to measu…

This study tests a special PET scan that uses a radioactive tracer to see how well breast cancer patients respond to a type of drug called an antibody-drug conjugate (ADC). The goal is to see if changes in tracer uptake can predict treatment success. About 50 adults with HER2-pos…

This study tests a new PET imaging method to detect a protein called CLDN18.2 in solid tumors. The goal is to identify patients who might benefit from treatments that target this protein. About 15 adults with solid tumors will receive a special tracer and then have a PET/CT scan.…

This study looks at whether a traditional Chinese herbal medicine, called modified Bufei decoction, can reduce common symptoms like cough, tiredness, and shortness of breath in people aged 65 and older who have had lung cancer surgery. About 174 participants will receive either t…

This study looks at people with early-stage lung cancer who had surgery and have no detectable tumor DNA in their blood. Half will get standard follow-up care, and the other half will have regular DNA tests and imaging instead of immediate extra treatment. The goal is to see if t…